Display options
Share it on

Adv Biomed Res. 2021 Feb 26;10:7. doi: 10.4103/abr.abr_173_20. eCollection 2021.

The Prevalence of Hepatitis B Virus Markers among Students of Shiraz University of Medical Sciences.

Advanced biomedical research

Razieh Dowran, Mahyar Malekzadeh, Tayyar Nourollahi, Bahador Sarkari, Jamal Sarvari

Affiliations

  1. Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  2. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  3. Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran.
  4. Department of Parasitology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  5. Department of Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 33959564 PMCID: PMC8095257 DOI: 10.4103/abr.abr_173_20

Abstract

BACKGROUND: Protection against hepatitis B virus (HBV) is based on the presence of antibodies against hepatitis B surface antigen (HBsAg). Vaccination of newborns is the most effective means of prevention. This study aimed to evaluate the frequency of anti-HBs antibody (anti-HBsAb), anti-HB core Ab (anti-HBcAb), HBsAg, and HBV DNA among university students in Fars province, Southern Iran.

MATERIALS AND METHODS: In this cross-sectional study, 272 students of Shiraz University of Medical Sciences, were enrolled. Venous blood (5 mL) was collected from each participant and centrifuged; the sera were stored at -20°C until use. Anti-HBsAb, Anti-HBcAb, and HBsAg were measured using a commercial enzyme-linked immunosorbent assay kit. HBV DNA load was also measured by a real-time polymerase chain reaction.

RESULTS: The mean age of the participants was 19 ± 1 years. There were 171 (62.9%) females and 101 (37.1%) males. Anti-HBsAb at a protective level (>10 mIU/mL) were detected in the sera of 104 (38.5%) of the cases. Of the anti-HBsAb seropositive participants, 82 were female and 22 were male; the difference between the gender and seropositivity to anti-HBsAb was statistically significant (

CONCLUSION: Findings of the current study show that more than half of the students do not have a protective level of anti-HBsAb and might be susceptible to HBV infection, indicating the necessity of checking the level of anti-HBsAb as well as a booster dose in high-risk groups.

Copyright: © 2021 Advanced Biomedical Research.

Keywords: Enzyme-Linked Immunosorbent Assay; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Virus; Student; Vaccination

Conflict of interest statement

There are no conflicts of interest.

References

  1. Vaccine. 2006 Jan 30;24(5):572-7 - PubMed
  2. Vaccine. 2011 Jul 18;29(32):5290-3 - PubMed
  3. Genes (Basel). 2018 Mar 02;9(3): - PubMed
  4. Clin Infect Dis. 2011 Jul 1;53(1):68-75 - PubMed
  5. Ann Agric Environ Med. 2017 Jun 12;24(2):303-306 - PubMed
  6. Am J Med. 1989 Sep 4;87(3A):36S-40S - PubMed
  7. Vaccine. 1999 Aug 6;17(23-24):2946-50 - PubMed
  8. Future Microbiol. 2019 Jun;14:41-44 - PubMed
  9. Spec Care Dentist. 2008 Nov-Dec;28(6):265-70 - PubMed
  10. J Public Health Afr. 2018 Oct 01;9(2):721 - PubMed
  11. Wien Med Wochenschr. 2020 Jun;170(9-10):218-223 - PubMed
  12. Hepat Mon. 2014 Jan 12;14(1):e13625 - PubMed
  13. Clin Liver Dis. 2004 May;8(2):283-300 - PubMed
  14. BMC Infect Dis. 2012 Dec 27;12:378 - PubMed
  15. Sci Rep. 2019 Sep 26;9(1):13948 - PubMed
  16. Vaccine. 2007 Apr 30;25(17):3511-4 - PubMed
  17. Arch Iran Med. 2019 Sep 01;22(9):501-504 - PubMed
  18. Braz J Infect Dis. 2019 Nov - Dec;23(6):419-426 - PubMed
  19. J Immunoassay Immunochem. 2020;41(1):20-27 - PubMed
  20. Pediatr Hematol Oncol. 2009 Jun;26(4):195-201 - PubMed
  21. Adv Biomed Res. 2015 Jan 30;4:17 - PubMed
  22. Electron Physician. 2013 Aug 01;5(3):659-63 - PubMed

Publication Types